Emory Report
Sept. 18, 2006
Volume 59, Number 4


Emory Report homepage  

Sept. 18, 2006
Emory partners with other universities, biotech industry for biodesign summit

Atlanta Mayor Shirley Franklin and Georgia’s 6th District congressman Tom Price, will be among the officials presiding at the opening ceremonies of the inaugural American International Medical Summit on Biotherapeutics and Medical Design (AIMS on Biodesign), Monday, Sept. 18, in Atlanta at the Omni CNN Center Hotel.

The two-and-a-half-day summit, from Sept. 18 to 20, is a groundbreaking collaboration among Georgia’s leading academic institutions and the Southeast medical device development industry. The program is presented by the Emory Woodruff Health Sciences Center and sponsored by Georgia Tech, the University of Georgia College of Pharmacy and the Medical College of Georgia.

A “President’s Roundtable,” featuring the presidents and leaders of these institutions is scheduled for the second day of the summit, Sept. 19, from 3:20 to 4:30 p.m.

Randy Martin, Emory cardiologist and WSB-TV health correspondent, will serve as emcee for the event, which also includes presenters from around the globe, such as representatives from London’s National Health System and the U.S. Food and Drug Administration, who will present meaningful, actionable methodologies to facilitate the development of new technologies and bring them to market.

AIMS on Biodesign will encourage and facilitate the development, invention and patenting of medical devices and provide a foundation for networking among scientific, legal and business audiences in the Southeast. The summit will focus on endovascular intervention in cardiology, cardiac and vascular surgery, interventional radiology, interventional neurovascular therapy and critical care medicine.

Michael Johns, executive vice president for health affairs at Emory, CEO of the Woodruff Health Sciences Center and chairman of the board of Emory Healthcare, is a key supporter and speaker at the event.

“This summit will demonstrate Emory’s commitment to the worldwide advancement of global initiatives in biodesign as it directly applies to patient care,” Johns said.